Perspectives on the ketogenic diet as a non-pharmacological intervention for major depressive disorder
Jade Shelp(Queen's University), Elisa Brietzke(Queen's University), Christopher Palmer(McLean Hospital), Jennifer Fabe(McMaster Children's Hospital), Elena Koning(Queen's University), Fabiano A. Gomes(McMaster University), Cristiano Chaves(Queen's University), Nicole Laurent(BC Mental Health & Substance Use Services), Vitor Breda(Western University), Alexander Roy Terpstra(St. Joseph’s Healthcare Hamilton)
Cited by 5
Related Papers
Performance of schizophrenic patients in the Stroop Color Word Test and electrodermal responsiveness after acute administration of cannabidiol (CBD)
|Brazilian Journal of Psychiatry|2010|122
Glutamate-N-methyl-D-aspartate receptor modulation and minocycline for the treatment of patients with schizophrenia: an update
|Brazilian Journal of Medical and Biological Research|2009|75
Effects of minocycline add-on treatment on brain morphometry and cerebral perfusion in recent-onset schizophrenia
|Schizophrenia Research|2014|41
Effects of nitric oxide-related compounds in the acute ketamine animal model of schizophrenia
|BMC Neuroscience|2015|40
Olanzapine, weight change and metabolic effects: a naturalistic 12-month follow up
|Therapeutic Advances in Psychopharmacology|2013|30